Praxis Precision Medicines, Inc.(PRAX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

PRAX Praxis Precision Medicines, Inc.

Post-Mkt 10-08 16:05:04 EDT

263.55

-14.47

-5.20%

盘后263.55

+0.000.00%

16:04 EDT

High273.96	Low260.07	Vol671.58K
Open273.74	D1 Closing278.02	Amplitude5.00%
Mkt Cap7.34B	Tradable Cap6.35B	Total Shares27.85M
T/O178.03M	T/O Rate2.79%	Tradable Shares24.08M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"PRAX","market":"US","secType":"STK","nameCN":"Praxis Precision Medicines, Inc.","latestPrice":263.55,"timestamp":1791489600000,"preClose":278.02,"halted":0,"volume":671577,"hourTrading":{"tag":"盘后","latestPrice":263.55,"preClose":263.55,"latestTime":"16:04 EDT","volume":25068,"amount":6606671.4,"timestamp":1791489845872,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.052046615351413465,"floatShares":24076500,"shares":27850833,"eps":-12.863398,"marketStatus":"Post-Mkt","change":-14.47,"latestTime":"10-08 16:05:04 EDT","open":273.74,"high":273.96,"low":260.07,"amount":178028937.91776,"amplitude":0.04996,"askPrice":268.69,"askSize":7,"bidPrice":262.98,"bidSize":2,"shortable":3,"etf":0,"ttmEps":-12.863398,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1791504000000},"marketStatusCode":4,"adr":0,"listingDate":1602820800000,"exchange":"NASDAQ","adjPreClose":278.02,"preHourTrading":{"tag":"盘前","latestPrice":277,"preClose":278.02,"latestTime":"09:27 EDT","volume":1054,"amount":291971.99712,"timestamp":1791466032054,"change":-1.02,"changeRate":-0.003669,"amplitude":0.048567},"postHourTrading":{"tag":"盘后","latestPrice":263.55,"preClose":263.55,"latestTime":"16:04 EDT","volume":25068,"amount":6606671.4,"timestamp":1791489845872,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":1.506859,"impliedVol":0.9063,"impliedVolPercentile":0.8805},"requestUrl":"/m/hq/s/PRAX/","defaultTab":"news","newsList":[{"id":"2673055452","title":"Praxis Precision price target raised to $826 from $810 at BTIG","url":"https://stock-news.laohu8.com/highlight/detail?id=2673055452","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673055452?lang=en_us&edition=fundamental","pubTime":"2026-10-06 19:31","pubTimestamp":1791286309,"startTime":"0","endTime":"0","summary":"BTIG raised the firm’s price target on Praxis Precision (PRAX) to $826 from $810 and keeps a Buy rating on the shares. With relutrigine’s December ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/praxis-precision-price-target-raised-to-826-from-810-at-btig-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/praxis-precision-price-target-raised-to-826-from-810-at-btig-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE00BJJMRZ35.SGD","IE0009355771.USD","IE0002141913.USD","PRAX","LU0109394709.USD","LU0320765992.SGD","IE00B2B36J28.USD","LU0889565916.HKD","BK4139","IE00BJT1NW94.SGD","IE00BFTCPJ56.SGD","IE00B4R5TH58.HKD","IBRN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673058928","title":"Praxis Precision Med is Maintained at Buy by BTIG","url":"https://stock-news.laohu8.com/highlight/detail?id=2673058928","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673058928?lang=en_us&edition=fundamental","pubTime":"2026-10-06 18:17","pubTimestamp":1791281820,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/PRAX/analyst-ratings","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0109394709.USD","IE00BFTCPJ56.SGD","BK4139","LU0889565916.HKD","IE00B4R5TH58.HKD","IE0002141913.USD","IE00B2B36J28.USD","IE00BJJMRZ35.SGD","IE00BJT1NW94.SGD","LU0320765992.SGD","IE0009355771.USD","IBRN","PRAX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672746732","title":"Praxis Precision Medicines Grants 3,478 Inducement RSUs to 14 New Employees Under 2024 Plan","url":"https://stock-news.laohu8.com/highlight/detail?id=2672746732","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672746732?lang=en_us&edition=fundamental","pubTime":"2026-10-03 04:01","pubTimestamp":1790971276,"startTime":"0","endTime":"0","summary":"Praxis Precision Medicines grants 3,478 inducement RSUs to 14 new employees under 2024 planPraxis Precision Medicines granted restricted stock units covering 3,478 common shares to 14 new non-executiv","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261002:nNDL8n5PWp:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BN0W2W23.USD","BK4112","BK4139","IE00B2B36J28.USD","LU0889565916.HKD","LU2210149790.SGD","SG9999014013.SGD","IE00BGHQF748.EUR","BK4588","LU0109394709.USD","SG9999014005.SGD","IE00BQXX3D17.EUR","LU2095319765.USD","IE00B64PRP62.GBP","BK4585","IBRN","IE00BN0W2V16.EUR","LU2210150020.SGD","NDAQ","IE00B3QW5Z07.USD","PRAX","SG9999014039.USD","BCDF","LU0314104364.USD","IE0009355771.USD","IE0002141913.USD","LU0320765992.SGD","IE00BJT1NW94.SGD","IE00BQXX3C00.GBP","IE00BKPKM429.USD","IE00BJJMRZ35.SGD","IE00B4R5TH58.HKD","SG9999014021.USD","IE00BQXX3F31.USD","IE00BN0W2T93.GBP","IE00BFTCPJ56.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672749918","title":"Praxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)","url":"https://stock-news.laohu8.com/highlight/detail?id=2672749918","media":"GlobeNewswire","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672749918?lang=en_us&edition=fundamental","pubTime":"2026-10-03 04:01","pubTimestamp":1790971260,"startTime":"0","endTime":"0","summary":"Investor Contact:. 857-702-9452. Media Contact:. Dan Ferry. LifeSci Advisors. 617-430-7576","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/10/02/3374007/0/en/praxis-precision-medicines-inc-announces-inducement-grants-under-nasdaq-listing-rule-5635-c-4.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4561","IBRN","CNS","IE00BJT1NW94.SGD","LCLG","ASO","IE00B2B36J28.USD","IE00B4R5TH58.HKD","BK4135","IE00BFTCPJ56.SGD","IE0002141913.USD","IE0009355771.USD","PRAX","LU0889565916.HKD","LU0109394709.USD","LU0320765992.SGD","BK4139","IE00BJJMRZ35.SGD","BK4200"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672379110","title":"Praxis Precision Medicines, Inc. : Jonestrading Raises Target Price to $534 from $441","url":"https://stock-news.laohu8.com/highlight/detail?id=2672379110","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672379110?lang=en_us&edition=fundamental","pubTime":"2026-10-02 12:50","pubTimestamp":1790916618,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261002:nFWN45O04U:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IBRN","BK4139","IE00B2B36J28.USD","IE00BJT1NW94.SGD","LU0320765992.SGD","LU0889565916.HKD","PRAX","LU0109394709.USD","IE00BJJMRZ35.SGD","IE0009355771.USD","IE0002141913.USD","IE00B4R5TH58.HKD","IE00BFTCPJ56.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672991762","title":"Analyst Justin Walsh Reiterates Buy on Praxis as Upgraded Relutrigine Forecast Triples Long-Term Revenue Potential","url":"https://stock-news.laohu8.com/highlight/detail?id=2672991762","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672991762?lang=en_us&edition=fundamental","pubTime":"2026-10-02 04:35","pubTimestamp":1790886921,"startTime":"0","endTime":"0","summary":"JonesTrading analyst Justin Walsh has reiterated their bullish stance on PRAX stock, giving a Buy rating on September 24. Justin Walsh has given hi...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/analyst-justin-walsh-reiterates-buy-on-praxis-as-upgraded-relutrigine-forecast-triples-long-term-revenue-potential-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/analyst-justin-walsh-reiterates-buy-on-praxis-as-upgraded-relutrigine-forecast-triples-long-term-revenue-potential-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","IE00BJT1NW94.SGD","LU0320765992.SGD","IE00B4R5TH58.HKD","IBRN","LU0889565916.HKD","PRAX","IE00BFTCPJ56.SGD","LU0109394709.USD","IE00BJJMRZ35.SGD","IE0002141913.USD","IE0009355771.USD","IE00B2B36J28.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669464161","title":"Analysts Offer Insights on Healthcare Companies: Praxis Precision Medicines (PRAX), Oruka Therapeutics (ORKA) and Harmony Biosciences Holdings (HRMY)","url":"https://stock-news.laohu8.com/highlight/detail?id=2669464161","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669464161?lang=en_us&edition=fundamental","pubTime":"2026-09-24 18:30","pubTimestamp":1790245831,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Praxis Precision Medicines (PRAX), Oruka Therapeutic...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-praxis-precision-medicines-prax-oruka-therapeutics-orka-and-harmony-biosciences-holdings-hrmy-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-praxis-precision-medicines-prax-oruka-therapeutics-orka-and-harmony-biosciences-holdings-hrmy-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE00B4R5TH58.HKD","IBRN","ORKA","LU0889565916.HKD","HCSG","BK4137","XLV","BK4139","LU0320765992.SGD","PRAX","IE00BJJMRZ35.SGD","BK4581","XBI","IE0009355771.USD","IE00B2B36J28.USD","BK4007","IE00BJT1NW94.SGD","LU0128526141.USD","LABU","IE0002141913.USD","BK4588","BK4585","HRMY","IE00BFTCPJ56.SGD","LU0109394709.USD","LU0029874061.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669613784","title":"Analyst Reiterates Buy on PRAX with Unchanged $582 Price Target Ahead of Key Phase 3 EMERALD Trial for Relutrigine","url":"https://stock-news.laohu8.com/highlight/detail?id=2669613784","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669613784?lang=en_us&edition=fundamental","pubTime":"2026-09-24 17:55","pubTimestamp":1790243718,"startTime":"0","endTime":"0","summary":"In a report released today, Ami Fadia from Needham reiterated a Buy rating on Praxis Precision Medicines, with a price target of $582.00. Ami Fadia...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/analyst-reiterates-buy-on-prax-with-unchanged-582-price-target-ahead-of-key-phase-3-emerald-trial-for-relutrigine-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/analyst-reiterates-buy-on-prax-with-unchanged-582-price-target-ahead-of-key-phase-3-emerald-trial-for-relutrigine-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PRAX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669469243","title":"Praxis Precision Med Price Target Maintained with a $582.00/Share by Needham","url":"https://stock-news.laohu8.com/highlight/detail?id=2669469243","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669469243?lang=en_us&edition=fundamental","pubTime":"2026-09-24 17:55","pubTimestamp":1790243700,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/PRAX/analyst-ratings","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0889565916.HKD","IE00B4R5TH58.HKD","BK4139","IE0009355771.USD","IE00BJJMRZ35.SGD","IE0002141913.USD","PRAX","LU0109394709.USD","IBRN","IE00B2B36J28.USD","IE00BFTCPJ56.SGD","IE00BJT1NW94.SGD","LU0320765992.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664480943","title":"Praxis Precision Medicines Grants RSUs for 11,535 Shares to 66 New Employees Under 2024 Inducement Plan","url":"https://stock-news.laohu8.com/highlight/detail?id=2664480943","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664480943?lang=en_us&edition=fundamental","pubTime":"2026-09-04 04:01","pubTimestamp":1788465672,"startTime":"0","endTime":"0","summary":"Praxis Precision Medicines grants RSUs for 11,535 shares to 66 new employees under 2024 inducement planPraxis Precision Medicines granted restricted stock units covering 11,535 common shares to 66 new","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260903:nNDLbxsWyw:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0889565916.HKD","LU2210149790.SGD","LU0109394709.USD","IE00BN0W2T93.GBP","IE00BKPKM429.USD","IE0009355771.USD","IE00BN0W2W23.USD","PRAX","IBRN","IE00BQXX3C00.GBP","SG9999014013.SGD","IE00B4R5TH58.HKD","LU2095319765.USD","SG9999014021.USD","BK4588","BK4585","IE00B3QW5Z07.USD","IE00BJJMRZ35.SGD","BCDF","IE0002141913.USD","IE00B2B36J28.USD","IE00BN0W2V16.EUR","NDAQ","IE00BJT1NW94.SGD","IE00BQXX3D17.EUR","IE00B64PRP62.GBP","LU0314104364.USD","IE00BFTCPJ56.SGD","LU2210150020.SGD","LU0320765992.SGD","IE00BQXX3F31.USD","SG9999014005.SGD","BK4139","SG9999014039.USD","BK4112","IE00BGHQF748.EUR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664180910","title":"Praxis Precision Medicines, Inc. Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)","url":"https://stock-news.laohu8.com/highlight/detail?id=2664180910","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664180910?lang=en_us&edition=fundamental","pubTime":"2026-09-04 04:01","pubTimestamp":1788465660,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260903:nTUAX4T6R:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IE00BFTCPJ56.SGD","IE00B4R5TH58.HKD","IE00B2B36J28.USD","IBRN","IE0009355771.USD","LU0109394709.USD","LU0889565916.HKD","IE00BJJMRZ35.SGD","IE00BJT1NW94.SGD","IE0002141913.USD","PRAX","LU0320765992.SGD","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664580111","title":"Praxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)","url":"https://stock-news.laohu8.com/highlight/detail?id=2664580111","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664580111?lang=en_us&edition=fundamental","pubTime":"2026-09-04 04:01","pubTimestamp":1788465660,"startTime":"0","endTime":"0","summary":"Investor Contact:. 857-702-9452. Media Contact:. Dan Ferry. LifeSci Advisors. 617-430-7576","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/03/3356230/0/en/praxis-precision-medicines-inc-announces-inducement-grants-under-nasdaq-listing-rule-5635-c-4.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B4R5TH58.HKD","IBRN","CNS","LU0889565916.HKD","BK4139","LU0320765992.SGD","ASO","PRAX","BK4200","IE00BJJMRZ35.SGD","BK4561","IE0009355771.USD","IE00B2B36J28.USD","IE00BJT1NW94.SGD","IE0002141913.USD","LCLG","IE00BFTCPJ56.SGD","LU0109394709.USD","BK4135"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1166217448","title":"Movement Alert｜Praxis Precision Medicines, Inc. Rises 5.15% in Regular Trading, Trading at $389.76","url":"https://stock-news.laohu8.com/highlight/detail?id=1166217448","media":"Market Focus","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1166217448?lang=en_us&edition=fundamental","pubTime":"2026-08-20 03:32","pubTimestamp":1787167942,"startTime":"0","endTime":"0","summary":"On August 20, Praxis Precision Medicines, Inc. rose 5.15% in regular trading, trading at $389.76/share, with Turnover of $114 million.Within the Biotechnology sector where Praxis Precision Medicines,...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PRAX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660043669","title":"Praxis Precision Medicines Could Be Approaching 'Perfect Trifecta,' Oppenheimer Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2660043669","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660043669?lang=en_us&edition=fundamental","pubTime":"2026-08-17 23:21","pubTimestamp":1786980102,"startTime":"0","endTime":"0","summary":"Praxis Precision Medicines (PRAX) could be approaching an unprecedented regulatory stretch, with four potential approvals across three drugs within roughly 12 months, a potential \"perfect trifecta,\" O","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IE0009355771.USD","IE00B4R5TH58.HKD","BK4139","LU0109394709.USD","LU0889565916.HKD","IE00BJJMRZ35.SGD","PRAX","IE00B2B36J28.USD","IBRN","LU0320765992.SGD","IE0002141913.USD","BK4127","IE00BJT1NW94.SGD","OPY","IE00BFTCPJ56.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660484118","title":"Praxis Precision Medicines, Inc. : Raymond James Raises Target Price to $945 from $765","url":"https://stock-news.laohu8.com/highlight/detail?id=2660484118","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660484118?lang=en_us&edition=fundamental","pubTime":"2026-08-17 19:10","pubTimestamp":1786965021,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260817:nFWN44E0K1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0320765992.SGD","IBRN","IE0009355771.USD","IE00BJT1NW94.SGD","LU0889565916.HKD","IE0002141913.USD","IE00BJJMRZ35.SGD","PRAX","IE00B2B36J28.USD","IE00B4R5TH58.HKD","BK4139","IE00BFTCPJ56.SGD","LU0109394709.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657641228","title":"Praxis Precision Med is Maintained at Equal-Weight by Wells Fargo","url":"https://stock-news.laohu8.com/highlight/detail?id=2657641228","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657641228?lang=en_us&edition=fundamental","pubTime":"2026-08-07 22:07","pubTimestamp":1786111620,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/PRAX/analyst-ratings","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0072461881.USD","LU2361044949.HKD","IE00BFTCPJ56.SGD","LU1814569148.SGD","LU1894683264.USD","LU0128525689.USD","BK4582","LU1201861249.SGD","FTXO","PGF","KBWB","LU0211327993.USD","PRAX","LU0868494708.USD","LU0320765489.SGD","LU0868494617.USD","LU0149725797.USD","IE00B19Z3581.USD","IE0002270589.USD","LU0310800965.SGD","LU1506573853.SGD","IE00BJJMRZ35.SGD","LU1280957306.USD","BK4559","LU0162691827.USD","LU0256863811.USD","BK4585","IBRN","IE0002141913.USD","LU1267930227.SGD","BK4139","LU2236285917.USD","LU2461242641.AUD","IE0009355771.USD","LU0320765992.SGD","LU0211328371.USD","LU1074936037.SGD","LU0417517546.SGD","LU0048573561.USD","LU0889565916.HKD","LU0971096721.USD","IE00BJT1NW94.SGD","BK4504","IE00B19Z3B42.SGD","LU0251142724.SGD","TFNS","BK4207","IYF","LU0640476718.USD","LU0742534661.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657645754","title":"Analysts Offer Insights on Healthcare Companies: Viatris (VTRS), Immunocore Holdings (IMCR) and Praxis Precision Medicines (PRAX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2657645754","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657645754?lang=en_us&edition=fundamental","pubTime":"2026-08-07 20:40","pubTimestamp":1786106428,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Viatris (VTRS), Immunocore Holdings (IMCR) and Pra...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-viatris-vtrs-immunocore-holdings-imcr-and-praxis-precision-medicines-prax-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-viatris-vtrs-immunocore-holdings-imcr-and-praxis-precision-medicines-prax-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IMCR","LU0889565916.HKD","VTRS","IE0002141913.USD","LU0320765992.SGD","IE00BJT1NW94.SGD","PRAX","BK4583","LU0109394709.USD","LU0128526141.USD","LU1839511570.USD","LU0029874061.USD","BK4007","LABU","IE00B2B36J28.USD","HCSG","BK4581","BK4585","LU2087621335.USD","XBI","IE00BJJMRZ35.SGD","BK4588","BK4137","BK4505","XLV","IE00BFTCPJ56.SGD","BK4139","IE00B4R5TH58.HKD","IE0009355771.USD","IBRN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657643664","title":"Praxis Precision price target raised to $514 from $400 at Baird","url":"https://stock-news.laohu8.com/highlight/detail?id=2657643664","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657643664?lang=en_us&edition=fundamental","pubTime":"2026-08-07 20:01","pubTimestamp":1786104075,"startTime":"0","endTime":"0","summary":"Baird raised the firm’s price target on Praxis Precision (PRAX) to $514 from $400 and keeps an Outperform rating on the shares. The firm updated it...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/praxis-precision-price-target-raised-to-514-from-400-at-baird-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/praxis-precision-price-target-raised-to-514-from-400-at-baird-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0320765992.SGD","IBRN","IE0009355771.USD","IE00BJT1NW94.SGD","LU0889565916.HKD","IE0002141913.USD","IE00BJJMRZ35.SGD","PRAX","IE00B2B36J28.USD","IE00B4R5TH58.HKD","BK4139","IE00BFTCPJ56.SGD","LU0109394709.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657648808","title":"Praxis Precision Medicines, Inc. : Deutsche Bank Raises Target Price to $475 from $374","url":"https://stock-news.laohu8.com/highlight/detail?id=2657648808","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657648808?lang=en_us&edition=fundamental","pubTime":"2026-08-07 19:26","pubTimestamp":1786101999,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260807:nFWN44419L:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0320765992.SGD","IE0002141913.USD","IE00B4R5TH58.HKD","IE00BJJMRZ35.SGD","IE00BJT1NW94.SGD","LU0109394709.USD","PRAX","BK4139","IE0009355771.USD","IBRN","IE00B2B36J28.USD","LU0889565916.HKD","IE00BFTCPJ56.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657650957","title":"Definium Therapeutics Q2 Net Loss Widens on Higher Warrant Costs","url":"https://stock-news.laohu8.com/highlight/detail?id=2657650957","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657650957?lang=en_us&edition=fundamental","pubTime":"2026-08-07 04:17","pubTimestamp":1786047436,"startTime":"0","endTime":"0","summary":"Definium Therapeutics Q2 net loss widens on higher warrant costsOverviewUS biopharma firm's Q2 net loss widens, driven by higher warrant liabilities and expensesCompany raised $805 mln in public offer","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260806:nL1N4431D2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","DTIL","LU0109394709.USD","LU0889565916.HKD","IE00B2B36J28.USD","IE00B4R5TH58.HKD","IE0002141913.USD","IE00BJJMRZ35.SGD","VTVT","IE00BJT1NW94.SGD","BK4139","IE00BFTCPJ56.SGD","PRAX","LU0320765992.SGD","IBRN","IE0009355771.USD","DFTX"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.praxismedicines.com","stockEarnings":[{"period":"1week","weight":-0.0454},{"period":"1month","weight":-0.2097},{"period":"3month","weight":-0.1654},{"period":"6month","weight":-0.1206},{"period":"1year","weight":4.3424},{"period":"ytd","weight":-0.0567}],"compareEarnings":[{"period":"1week","weight":0.0191},{"period":"1month","weight":0.0091},{"period":"3month","weight":0.0339},{"period":"6month","weight":0.1439},{"period":"1year","weight":0.1616},{"period":"ytd","weight":0.1398}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Praxis Precision Medicines, Inc., a clinical-stage biopharmaceutical company, develops therapies for central nervous system disorders characterized by neuronal excitation-inhibition imbalance. It is developing ulixacaltamide, a small molecule inhibitor of T-type calcium channels that is in Phase IIb clinical trial for the treatment of essential tremor, as well as in Phase II clinical trial to treat Parkinson's disease; PRAX-562 for the treatment of pediatric patients with developmental and epileptic encephalopathies (DEE); and PRAX-628 to treat focal epilepsy. The company also develops PRAX-222 for the treatment of pediatric patients with early-onset SCN2A-DEE; PRAX-020 to treat KCNT1 related epilepsies; PRAX-080 for the treatment of PCDH19; and PRAX-090 and PRAX-100 for SYNGAP1 and SCN2A-LoF. It has a license agreement with RogCon Inc.; a research collaboration and license agreement with Ionis Pharmaceuticals, Inc.; a strategic collaboration and license agreement with UCB Biopharma SRL; and collaboration with The Florey Institute to develop three novel ASOs. Praxis Precision Medicines, Inc. was incorporated in 2015 and is based in Boston, Massachusetts.","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":0.298328},{"month":2,"riseRate":0.333333,"avgChangeRate":-0.166549},{"month":3,"riseRate":0.166667,"avgChangeRate":-0.160217},{"month":4,"riseRate":0.166667,"avgChangeRate":-0.017086},{"month":5,"riseRate":0.5,"avgChangeRate":-0.087139},{"month":6,"riseRate":0.333333,"avgChangeRate":-0.085881},{"month":7,"riseRate":0.5,"avgChangeRate":0.12656},{"month":8,"riseRate":0.5,"avgChangeRate":0.090189},{"month":9,"riseRate":0.5,"avgChangeRate":-0.016807},{"month":10,"riseRate":0.5,"avgChangeRate":0.419386},{"month":11,"riseRate":0.666667,"avgChangeRate":0.073478},{"month":12,"riseRate":0.833333,"avgChangeRate":0.206625}],"exchange":"NASDAQ","name":"Praxis Precision Medicines, Inc.","nameEN":"Praxis Precision Medicines, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.50.1","shortVersion":"4.50.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Praxis Precision Medicines, Inc.(PRAX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Praxis Precision Medicines, Inc.(PRAX) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Praxis Precision Medicines, Inc.,PRAX,Praxis Precision Medicines, Inc.股票,Praxis Precision Medicines, Inc.股票老虎,Praxis Precision Medicines, Inc.股票老虎国际,Praxis Precision Medicines, Inc.行情,Praxis Precision Medicines, Inc.股票行情,Praxis Precision Medicines, Inc.股价,Praxis Precision Medicines, Inc.股市,Praxis Precision Medicines, Inc.股票价格,Praxis Precision Medicines, Inc.股票交易,Praxis Precision Medicines, Inc.股票购买,Praxis Precision Medicines, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Praxis Precision Medicines, Inc.(PRAX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Praxis Precision Medicines, Inc.(PRAX) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction